Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
5 studies found for:    HLA-DQB1
Hide Display Options

Display Options

Study Details
Participant Details
Rank Status Study
1 Recruiting HLA-DRB1 and HLA-DQB1 Genotyping for Autoantibody-positive and -Negative Patients With Atrophic Glossitis or Burning Mouth Syndrome
Condition: Atrophic Glossitis, Burning Mouth Syndrome
Intervention: Dietary Supplement: Supplementation of vitamin B complex, C, B12, folic acid, Iron and Zinic
2 Recruiting Chronic Infection With Tropheryma Whipplei: Risk Factors Related to the Host
Condition: Whipple Infection
Intervention: Biological: Blood Sample
3 Completed NGS for HLA Typing of Donors and récipients oh Hematopoietic Stem Cells
Condition: Next Generation Sequencing for HLA Typing
4 Completed Hepatitis B Vaccine Genetics: A Substudy of ATN 024 and ATN 025
Conditions: HIV Infection;   Hepatitis B
5 Recruiting Dose Escalation Trial of WT1-specific Donor-derived T Cells Following T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Relapsed/Refractory Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: busulfan;   Drug: melphalan;   Drug: fludarabine;   Biological: anti-thymocyte globulin (ATG);   Procedure: a T cell depleted stem cell transplant

Indicates status has not been verified in more than two years